Novo Holdings A/S - INTERSECT ENT INC ownership

INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 115 filers reported holding INTERSECT ENT INC in Q3 2020. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
Novo Holdings A/S ownership history of INTERSECT ENT INC
ValueSharesWeighting
Q2 2021$8,697,000
-18.2%
508,9220.0%0.39%
-12.1%
Q1 2021$10,626,000
-7.6%
508,922
+1.3%
0.44%
-11.0%
Q4 2020$11,501,000
+37.3%
502,225
-2.2%
0.49%
+18.5%
Q3 2020$8,375,000
+10.8%
513,515
-8.1%
0.42%
-14.8%
Q2 2020$7,562,000
+72.2%
558,515
+50.7%
0.49%
+66.6%
Q1 2020$4,392,000
-19.0%
370,595
+70.2%
0.29%
-16.0%
Q4 2019$5,421,000
+46.4%
217,7090.0%0.35%
-45.0%
Q3 2019$3,703,000
+18.8%
217,709
+59.0%
0.63%
+45.1%
Q2 2019$3,116,000136,8850.44%
Q1 2015$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q4 2014$6,492,000
+19.7%
350,0000.0%0.52%
-0.8%
Q3 2014$5,425,000350,0000.53%
Other shareholders
INTERSECT ENT INC shareholders Q3 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,332,773$27,828,0005.75%
First Light Asset Management, LLC 2,036,645$42,525,0002.82%
Altium Capital Management LP 141,856$2,962,0000.82%
PURA VIDA INVESTMENTS, LLC 909,660$18,994,0000.54%
Rock Springs Capital Management LP 1,080,200$22,555,0000.49%
Novo Holdings A/S 508,922$10,626,0000.44%
Davide Leone & Partners Investment Co Ltd. 109,240$2,281,0000.28%
PURA VIDA INVESTMENTS, LLC 256,800$5,362,0000.15%
Bellevue Group AG 617,968$12,903,0000.14%
Gyon Technologies Capital Management, LP 13,318$278,0000.12%
View complete list of INTERSECT ENT INC shareholders